Anavex Life Sciences has announced promising findings from their Phase 2b/3 trial of blarcamesine, a novel therapeutic candidate for early Alzheimer’s disease (AD). The investigational drug, also known as ANAVEX2-73, by Anavex, showed significant efficacy in reducing amyloid-ß biomarkers and slowing cognitive decline in patients. The multicenter, randomized, double-blind, placebo-controlled study involved 508 participants from […]
Day: October 13, 2024
Alliance Defending Freedom: Guardians of Constitutional Rights
Alliance Defending Freedom (ADF), established in 1994, stands as the world’s largest legal organization committed to protecting religious freedom, free speech, family, parental rights, and the sanctity of life. This group has played a pivotal role in defending these fundamental rights, not just within the United States, but globally. ADF has been involved in numerous […]